Zobrazeno 1 - 10
of 97
pro vyhledávání: '"Ana Matilla"'
Autor:
Laura Carrión, Ana Clemente-Sánchez, Laura Márquez-Pérez, Javier Orcajo-Rincón, Amanda Rotger, Enrique Ramón-Botella, Manuel González-Leyte, Miguel Echenagusía-Boyra, Arturo Luis Colón, Laura Reguera-Berenguer, Rafael Bañares, Diego Rincón, Ana Matilla-Peña
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 16 (2023)
Background: Transarterial radioembolization (TARE) is increasingly used in patients with hepatocellular carcinoma (HCC). This treatment can induce or impair portal hypertension, leading to hepatic decompensation. TARE also promotes changes in liver a
Externí odkaz:
https://doaj.org/article/1e433dea276e4f3d8e2c5c349b64613f
Autor:
Javier Orcajo Rincón, Amanda Rotger Regi, Ana Matilla Peña, Laura Reguera Berenguer, Manuel González Leyte, Laura Carrión Martín, Jaime Atance García De La Santa, Miguel Echenagusia Boyra, Cristina González Ruiz, Arturo Colón Rodríguez, Juan Carlos Alonso Farto
Publikováno v:
EJNMMI Physics, Vol 10, Iss 1, Pp 1-14 (2023)
Abstract Objective Advances in hepatic radioembolization are based on a selective approach with radical intent and the use of multicompartment dosimetric analysis. The objective of this study is to assess the utility of voxel-based dosimetry in the q
Externí odkaz:
https://doaj.org/article/92173cb24294434ea838a514a8d249a7
Autor:
Bruno Sangro, Maria Reig, Carlos Gómez-Martin, Josepmaria Argemi, Mercedes Iñarrairaegui, Laura Marquez, Manuel de la Torre-Aláez, Ana Matilla, Maria Varela, Jose Luis Lledó, Juan Ignacio Arenas, Sara Lorente, Milagros Testillano, Leonardo Da Fonseca, Macarena Rodriguez-Fraile, Jose I Bilbao
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 11 (2022)
Purpose To evaluate the safety and efficacy of selective internal radiation therapy (SIRT) in combination with a PD-1 inhibitor in patients with unresectable hepatocellular carcinoma (uHCC) and liver-only disease ineligible for chemoembolization.Pati
Externí odkaz:
https://doaj.org/article/e79ce69697db40a1966c37c1077aa4d6
Autor:
Ana Matilla Peña, Óscar Núñez-Martínez, Antonio Díaz-Sánchez, Fernando Pons-Renedo, Mariano Gómez-Rubio, Benjamín Polo-Lorduy, José L. Lledó-Navarro, María Trapero-Marugán, José María Ladero-Quesada, Elvira Poves-Martínez, Alberto Ibáñez-Pinto, Ana María Martín-Algívez, Mar Lozano-Maya, Raquel González-Alonso, Belén Piqueras-Alcol, Leticia González-Moreno, Conrado Fernández-Rodríguez, Francisco Gea-Rodríguez
Publikováno v:
Annals of Hepatology, Vol 14, Iss 2, Pp 207-217 (2015)
Background. Transarterial chemoembolisation (TACE), having demonstrated survival benefits, is the treatment of choice in intermediate-stage hepatocellular carcinoma, although there is great heterogeneity in its clinical application.Material and metho
Externí odkaz:
https://doaj.org/article/8dbddec9e2f346b29942633fb773568f
Autor:
ANA MATILLA ROMERO
Publikováno v:
Res Diachronicae Virtual, Vol 13, Pp 40-48 (2015)
La investigación de la que trata mi artículo es una parte de lo que presenté como Trabajo Fin de Grado, en la Universidad de Sevilla, dirigido por la Dra. Lola Pons Rodríguez. En este trabajo he realizado un estudio de los apartados primero
Externí odkaz:
https://doaj.org/article/1461ff8608fb4a65af3f18fc6cd082ee
Autor:
Antonio Diaz-Sanchez, Ana Matilla, Oscar Nuñez, Diego Rincon, Raquel Lorente, Oreste Lo lacono, Beatriz Merino, Ana Hernando, Rocio Campos, Gerardo Clemente, Rafael Bañares
Publikováno v:
Annals of Hepatology, Vol 12, Iss 2, Pp 236-247 (2013)
Background. VCAM-1 (soluble vascular cell adhesion molecule-1) plays a role in liver angiogenesis. Hepatocellular carcinoma (HCC) has important angiogenic activity, so expression of VCAM-1 may be pathogenic. Aim. To assess the association between ser
Externí odkaz:
https://doaj.org/article/04be7633f367418d98564de37e7c8d43
Autor:
Thomas Yau, Vittorina Zagonel, Armando Santoro, Mirelis Acosta-Rivera, Su Pin Choo, Ana Matilla, Aiwu Ruth He, Antonio Cubillo Gracian, Anthony B. El-Khoueiry, Bruno Sangro, Tarek E. Eldawy, Jordi Bruix, Giovanni Luca Frassineti, Gina M. Vaccaro, Marina Tschaika, Christian Scheffold, Petra Koopmans, Jaclyn Neely, Fabio Piscaglia
Publikováno v:
Journal of Clinical Oncology. 41:1747-1757
PURPOSE To investigate the safety and efficacy of nivolumab plus cabozantinib with or without ipilimumab in patients with advanced hepatocellular carcinoma. METHODS In cohort 6 of the multicohort, open-label, phase I/II CheckMate 040 study, patients
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Peña, Ana Matilla, Núñez-Martínez, Óscar *, Díaz-Sánchez, Antonio, Pons-Renedo, Fernando, Gómez-Rubio, Mariano, Polo-Lorduy, Benjamín, Lledó-Navarro, José L., Trapero-Marugán, María, Ladero-Quesada, José María, Poves-Martínez, Elvira, Ibáñez-Pinto, Alberto, Martín-Algívez, Ana María, Lozano-Maya, Mar, González-Alonso, Raquel, Piqueras-Alcol, Belén, González-Moreno, Leticia, Fernández-Rodríguez, Conrado, Gea-Rodríguez, Francisco
Publikováno v:
In Annals of Hepatology March-April 2015 14(2):207-217
Autor:
Manuel de la Torre-Aláez, Ana Matilla, Maria Varela, Mercedes Iñarrairaegui, Maria Reig, Jose Luis Lledó, Juan Ignacio Arenas, Sara Lorente, Milagros Testillano, Laura Márquez, Leonardo Da Fonseca, Josepmaria Argemí, Carlos Gómez-Martin, Macarena Rodriguez-Fraile, Jose I Bilbao, Bruno Sangro
Publikováno v:
Scopus
PurposeTo evaluate the safety and efficacy of selective internal radiation therapy (SIRT) in combination with a PD-1 inhibitor in patients with unresectable hepatocellular carcinoma (uHCC) and liver-only disease ineligible for chemoembolization.Patie